RESEARCH MONOGRAPH · KDC-MN-148

Acetyl-L-Carnitine (ALCAR)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

77/100

A solid mitochondrial cofactor with real neurological signal and a more modest effect size than the supplement market suggests

Acetyl-L-Carnitine is the acetylated form of L-carnitine, which serves as the obligate shuttle for long-chain fatty acids into the mitochondrial matrix for beta-oxidation via the carnitine palmitoyltransferase system. The acetylation gives ALCAR an extra trick: the acetyl group can be donated to acetyl-CoA pools, which feeds into the citric acid cycle and into acetylcholine synthesis, and ALCAR crosses the blood-brain barrier better than free carnitine, which matters for the neurological applications.

The most replicated clinical signal for ALCAR is in painful diabetic neuropathy, with multiple trials showing improvements in nerve conduction parameters and pain scores. Sima and colleagues did some of the key work. There's also reasonably consistent data in age-related cognitive decline, with effect sizes that are modest but real, and in chemotherapy-induced peripheral neuropathy where the data is mixed.

What we like: mechanistically coherent and overlapping with multiple plausible therapeutic angles. The mitochondrial energetics piece is real biology, the acetyl donor role makes sense, the BBB penetration is genuine. The diabetic neuropathy data has held up reasonably well across replication attempts, which is a higher bar than most supplement-tier compounds clear.

What we dont like: the cognitive enhancement marketing oversells the modest effect sizes. The published meta-analyses on cognition in aging show effect sizes that are statistically significant but small. Also long-term carnitine supplementation has some metabolic complexity around TMAO production by gut microbiota, which has gotten interest in the cardiovascular literature; whether that matters at typical research doses isnt fully settled.

Mechanism: well-mapped at the level of mitochondrial fatty acid transport. The neurological effects are partly mapped, with the cholinergic donation and antioxidant pathways being the leading candidates.

Sourcing: well-established amino acid derivative, cheap to manufacture, characterized to pharmacopoeia standards by major suppliers. Get a COA verifying it's the L-isomer and not racemic (D-carnitine can interfere with L-carnitine transport).

Workhorse mitochondrial cofactor with real neurological signal at the level of nerve fibers, more modest signal at the level of cognition. The diabetic neuropathy literature is the underappreciated angle.

Evidence: 75
Mechanism: 80
Reliability: 70
Safety: 85
Sourcing: 88
Value: 80
Signal: 65
Staying power: 70

Plain-language summary Intrigue 60 / 100

Acetyl-L-carnitine (ALCAR) is the acetylated form of carnitine, an amino acid derivative that shuttles fatty acids into mitochondria for energy production. ALCAR additionally crosses the blood-brain barrier and donates an acetyl group to acetylcholine synthesis. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Acetylated carnitine / mitochondrial cofactor

An acetylated form of L-carnitine with improved CNS penetration, studied for cognitive impairment, neuropathy, and depression.

Abstract

Acetyl-L-Carnitine (ALCAR; CAS 3040-38-8; molecular formula C9H17NO4; molecular weight 203.24) is an acetylated form of L-carnitine that crosses the blood-brain barrier more efficiently than carnitine itself. Inside cells, ALCAR is hydrolyzed to acetyl-CoA and L-carnitine, both of which contribute to mitochondrial fatty acid oxidation and energy metabolism. The compound has been studied in cognitive impairment, diabetic peripheral neuropathy, depression (modest efficacy in mild-to-moderate depression), and male fertility. The compound is sold as a dietary supplement. Reported research dose ranges in the literature are described in the source publications.

Mechanism of action

Acetylated carnitine with improved BBB penetration. Hydrolyzed centrally to acetyl-CoA and L-carnitine; mitochondrial fatty acid oxidation cofactor.

Reported research dose ranges

Reported research dose ranges in the literature.

References

Veronese N, et al. Acetyl-L-carnitine supplementation and the treatment of depressive symptoms: a systematic review and meta-analysis. Psychosom Med 2018.

Read the full monograph

The full reference document is available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-148

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Acetyl-L-Carnitine (ALCAR)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs